Glucose (Tablets, Solution, Powder) Instructions for Use
ATC Code
B05BA03 (Carbohydrates)
Active Substance
Dextrose (Ph.Eur.)
Clinical-Pharmacological Group
Drug for rehydration and detoxification for parenteral use
Pharmacotherapeutic Group
Carbohydrate nutrition agent
Pharmacological Action
It participates in various metabolic processes in the body. Infusion of dextrose solutions partially replenishes water deficit.
Dextrose, upon entering the tissues, is phosphorylated, converting into glucose-6-phosphate, which is actively involved in many links of the body’s metabolism. A 5% dextrose solution is isotonic to blood plasma.
Hypertonic solutions (10%, 20%, 40%) increase the osmotic pressure of the blood and increase diuresis. The theoretical osmolarity of 10% dextrose is 555 mOsm/l, 20% – 1110 mOsm/l.
Pharmacokinetics
It is completely absorbed by the body, not excreted by the kidneys (its appearance in urine is a pathological sign).
Indications
- Hypoglycemia;
- Carbohydrate nutrition deficiency;
- Toxic infection;
- Intoxication in liver diseases (hepatitis, dystrophy and liver atrophy, including hepatic failure);
- Hemorrhagic diathesis;
- Dehydration (vomiting, diarrhea, postoperative period);
- Intoxication;
- Collapse;
- Shock.
ICD codes
| ICD-10 code | Indication |
| A05 | Other bacterial food poisonings, not elsewhere classified |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| B15 | Acute hepatitis A |
| B16 | Acute hepatitis B |
| B17.1 | Acute hepatitis C |
| B18 | Chronic viral hepatitis |
| D69 | Purpura and other haemorrhagic conditions |
| E16.0 | Drug-induced hypoglycaemia without coma |
| E16.1 | Other forms of hypoglycemia (hyperinsulinism) |
| E86 | Volume depletion (including dehydration, hypovolemia) |
| K59.1 | Functional diarrhea |
| K72 | Hepatic failure, not elsewhere classified (including hepatic coma, hepatic encephalopathy) |
| K74 | Fibrosis and cirrhosis of liver |
| R11 | Nausea and vomiting |
| R54 | Acute intoxication |
| R55 | Syncope [syncopal attack] and collapse |
| R57 | Shock, not elsewhere classified |
| ICD-11 code | Indication |
| 1A1Z | Bacterial foodborne intoxications, unspecified |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| 1E50.0 | Acute hepatitis A |
| 1E50.1 | Acute hepatitis B |
| 1E50.2 | Acute hepatitis C |
| 1E51.Z | Chronic viral hepatitis, unspecified |
| 3B4Z | Coagulation disorders, unspecified |
| 3B60 | Nonthrombocytopenic purpura |
| 3B62.Z | Thrombocytopathy, unspecified |
| 3B64.1 | Acquired thrombocytopenia |
| 3B64.10 | Immune thrombocytopenic purpura |
| 3B64.11 | Secondary thrombocytopenia |
| 3B64.12 | Drug-induced thrombocytopenic purpura |
| 3B64.13 | Alloimmune thrombocytopenia |
| 3B64.Z | Thrombocytopenia, unspecified |
| 3B6Z | Disorders of blood coagulation, purpura and other hemorrhagic or related conditions, unspecified |
| 4A44.92 | IgA vasculitis |
| 4A85.02 | Drug-induced cytopenia |
| 4A85.03 | Drug-induced vasculitis |
| 5A41 | Hypoglycemia, not associated with diabetes |
| 5A4Z | Disorders of glucose regulation or pancreatic internal secretion, unspecified |
| 5C70.Z | Decrease of volume of fluid [hypovolemia], unspecified |
| DB91.Z | Unspecified acute or subacute liver failure |
| DB93 | Fibrosis or cirrhosis of liver |
| DB99.7 | Hepatic failure, not specified as acute or chronic |
| DB99.8 | Chronic hepatic failure |
| DB9Z | Liver diseases, unspecified |
| DD91.2 | Functional diarrhea |
| DD93.Y | Other specified functional gastrointestinal disorders in infants, toddlers and school-age children |
| DD9Z | Functional gastrointestinal disorders, unspecified |
| EF30 | Purpura or ecchymoses due to coagulation disorders |
| EF31 | Traumatic purpura |
| EF3Z | Purpura of unspecified etiology |
| MD90 | Nausea or vomiting |
| MG2A | Frailty syndrome |
| MG40.Z | Shock, unspecified |
| MG45.Z | Syncope and collapse, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Solution
Intravenously by drip.
A 5% solution is administered at a maximum rate of up to 7 ml (150 drops)/min (400 ml/h); the maximum daily dose for adults is 2 L.
A 10% solution – up to 60 drops/min (3 ml/min); the maximum daily dose for adults is 1 L.
A 20% solution – up to 30-40 drops/min (1.5-2 ml/min); the maximum daily dose for adults is 500 ml.
A 40% solution – up to 30 drops/min (1.5 ml/min); the maximum daily dose for adults is 250 ml.
Intravenously by bolus.
10-50 ml of 5% and 10% solutions.
In adults with normal metabolism, the daily dose of administered glucose should not exceed 4-6 g/kg, i.e., about 250-450 g (with a decrease in metabolic rate, the daily dose is reduced to 200-300 g), while the volume of fluid administered is 30-40 ml/kg.
For children for parenteral nutrition, on the first day, 6 g of glucose/kg/day is administered, subsequently – up to 15 g/kg/day, along with glucose, fats and amino acids are administered if necessary.
When calculating the glucose dose when administering 5% and 10% solutions, the permissible volume of fluid administered should be taken into account: for children weighing 2-10 kg – 100-165 ml/kg/day, for children weighing 10-40 kg – 45-100 ml/kg/day.
With normal metabolic status, the maximum rate of glucose administration for adults is 0.25-0.5 g/kg/h (with a decrease in metabolic rate, the administration rate is reduced to 0.125-0.25 g/kg/h). In children, solutions with a concentration not exceeding 20-25% are used; the rate of glucose administration should not exceed 0.75 g/kg/h.
Tablets, Powder
IV drip.
5% solution: maximum up to 150 drops/min, maximum daily dose for adults – 2 L;
10% solution: maximum up to 60 drops/min, maximum daily dose for adults – 500 ml;
20% solution: maximum up to 40 drops/min, maximum daily dose for adults – 300 ml;
40% solution: maximum up to 30 drops/min, maximum daily dose for adults – 250 ml.
Orally.
Adverse Reactions
Hypervolemia, acute left ventricular failure; if the infusion rate is exceeded – osmotic diuresis with loss of water, electrolytes and development of hyperosmolar coma. At the injection site – development of infection, thrombophlebitis.
Contraindications
- Hyperglycemia;
- Hyperlactacidemia;
- Hyperhydration;
- Postoperative disorders of glucose utilization;
- Circulatory disorders threatening cerebral and pulmonary edema;
- Cerebral edema;
- Pulmonary edema;
- Acute left ventricular failure;
- Hyperosmolar coma;
- Childhood (for solutions over 20-25%);
- Hypersensitivity.
With caution decompensated chronic heart failure, chronic renal failure (oligo-, anuria), hyponatremia, diabetes mellitus.
Use in Pregnancy and Lactation
There are no data on the negative effect of the drug during the specified period.
Use in Renal Impairment
With caution: chronic renal failure.
Pediatric Use
Contraindicated in childhood (for solutions over 20-25%).
Special Precautions
Monitoring of water-electrolyte balance.
To increase osmolarity, a 5% solution can be combined with an isotonic sodium chloride solution.
For more complete and rapid absorption of glucose administered in large doses, 4-5 units of short-acting insulin can be administered subcutaneously simultaneously with it, based on 1 unit of insulin per 4-5 g of glucose.
In patients with diabetes mellitus, glucose is administered under the control of its content in the blood and urine.
Effect on ability to drive vehicles and operate machinery
No negative impact on the ability to drive vehicles and work with machinery has been identified.
Overdose
Symptoms hyperglycemia, glucosuria, hyperglycemic, hyperosmolar coma, hyperhydration, disturbance of water-electrolyte balance, increased liponeogenesis with increased production of CO2, which leads to a sharp increase in minute respiratory volume and, as a consequence, respiratory rate, fatty infiltration of the liver.
Treatment discontinue glucose administration, administer short-acting insulin, symptomatic therapy.
Drug Interactions
When combined with other drugs, it is necessary to monitor pharmaceutical compatibility, including visually.
Storage Conditions
At a temperature from 5 to 30°C (86°F). Keep out of reach of children.
Shelf Life
Shelf life – 3 years.
Dispensing Status
By prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Solution for infusion 5%: containers 250 ml or 500 ml
Marketing Authorization Holder
Avexima Siberia LLC (Russia)
Dosage Form
 |
Glucose | Solution for infusion 5%: containers 250 ml or 500 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
250 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
Solution for infusion 10%: containers 250 ml or 500 ml
Marketing Authorization Holder
Avexima Siberia LLC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: containers 250 ml or 500 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
250 ml – polymer containers (1) – polymer bags (24) – cardboard boxes.
500 ml – polymer containers (1) – polymer bags (12) – cardboard boxes.
Infusion solution 5%: bottle 100 ml, 200 ml or 400 ml.
Marketing Authorization Holder
Akapharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: bottle 100 ml, 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – bottles (1) – cardboard packs*.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs*.
Infusion solution 10%: bottle 100 ml, 200 ml or 400 ml.
Marketing Authorization Holder
Akapharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: bottle 100 ml, 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
100 ml – bottles (1) – cardboard packs*.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs*.
Infusion solution 20%: bottle 100 ml, 200 ml or 400 ml.
Marketing Authorization Holder
Akapharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: bottle 100 ml, 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
100 ml – bottles (1) – cardboard packs*.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs*.
Infusion solution 40%: bottle 100 ml, 200 ml or 400 ml.
Marketing Authorization Holder
Akapharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 40%: bottle 100 ml, 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 40% | 100 ml |
| Dextrose | 40 g |
100 ml – bottles (1) – cardboard packs*.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs*.
Infusion solution 5%: container 250 ml or 500 ml
Infusion solution 10%: container 250 ml or 500 ml
Infusion solution 20%: container 250 ml or 500 ml
Infusion solution 40%: container 250 ml or 500 ml
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
Dosage Forms
|
Glucose | Infusion solution 5%: container 250 ml or 500 ml |
| Infusion solution 10%: container 250 ml or 500 ml | ||
| Infusion solution 20%: container 250 ml or 500 ml | ||
| Infusion solution 40%: container 250 ml or 500 ml |
Dosage Form, Packaging, and Composition
Solution for infusion transparent colorless.
| 1 ml | |
| Dextrose | 0.05 g |
Excipients : sodium chloride 0.00026 g, hydrochloric acid solution 0.1 M to pH 3.0 – 4.1, water for injection up to 1 ml.
Theoretical osmolarity 277 mOsm/l
250 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
250 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
Solution for infusion transparent colorless.
| 1 ml | |
| Dextrose | 0.1 g |
Excipients : sodium chloride 0.00026 g, hydrochloric acid solution 0.1 M to pH 3.0 – 4.1, water for injection up to 1 ml.
Theoretical osmolarity 555 mOsm/l
250 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
250 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
Solution for infusion transparent from colorless to light yellow.
| 1 ml | |
| Dextrose | 0.2 g |
Excipients : sodium chloride 0.00026 g, hydrochloric acid solution 0.1 M to pH 3.0 – 4.1, water for injection up to 1 ml.
Theoretical osmolarity 1110 mOsm/l
250 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
250 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
Solution for infusion transparent from colorless to light yellow.
| 1 ml | |
| Dextrose | 0.4 g |
Excipients: sodium chloride 0.00026 g, hydrochloric acid 0.1 M solution to pH 3.0 – 4.1, water for injections up to 1 ml.
Theoretical osmolarity 2220 mOsm/l
250 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (1) complete with polymer tubes – polyethylene bags.
250 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
500 ml – polymer containers (10) – (90) complete with polymer tubes – polyethylene bags.
Solution for intravenous administration 40%: amp. 10 ml
Marketing Authorization Holder
Armavir Biopharmaceutical Plant, FSE (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 40%: amp. 10 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs (28) – cardboard boxes.
200 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
200 ml – bottles for blood and blood substitutes (28) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs (15) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
Solution for intravenous administration 400 mg/ml: 5 or 10 ml amp. 5 or 10 pcs.
Marketing Authorization Holder
Atoll LLC (Russia)
Manufactured By
Ozon, LLC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 400 mg/ml: 5 or 10 ml amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml |
| Dextrose | 400 mg |
5 ml – glass ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – glass ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – glass ampoules (5) – cardboard trays (1) – cardboard packs.
5 ml – glass ampoules (5) – cardboard trays (2) – cardboard packs.
10 ml – glass ampoules (5) – contour cell packaging (1) – cardboard packs.
10 ml – glass ampoules (5) – contour cell packaging (2) – cardboard packs.
10 ml – glass ampoules (5) – cardboard trays (1) – cardboard packs.
10 ml – glass ampoules (5) – cardboard trays (2) – cardboard packs.
Solution for intravenous administration 40%: amp. 5 ml or 10 ml 5 pcs., 5 ml or 10 ml 10 pcs.
Marketing Authorization Holder
Binnopharm JSC (Russia)
Manufactured By
Binnopharm JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 40%: amp. 5 ml or 10 ml 5 pcs., 5 ml or 10 ml 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration 40% | 100 ml |
| Dextrose | 40 g |
5 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
5 ml – ampoules (10) – contour cell packaging (1) – cardboard packs.
10 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
10 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
10 ml – ampoules (10) – contour cell packaging (1) – cardboard packs.
Solution for intravenous administration 2 g/5 ml: amp. 5 or 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 2 g/5 ml: amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 2 g |
5 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
5 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
Solution for intravenous administration 4 g/10 ml: amp. 5 or 10 pcs.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 4 g/10 ml: amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (5) – contour cell packaging (1) – cardboard packs.
10 ml – ampoules (5) – contour cell packaging (2) – cardboard packs.
Solution for infusion 5%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes.
400 ml – bottles for blood and blood substitutes.
Solution for infusion 10%: bottles 200 ml or 400 ml
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: bottles 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes.
400 ml – bottles for blood and blood substitutes.
Infusion solution 10%: vial 250 ml or 500 ml
Marketing Authorization Holder
Gematek, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: vial 250 ml or 500 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
250 ml – polyethylene vials.
250 ml – polyethylene vials (15) – cardboard boxes.
500 ml – polyethylene vials (10) – cardboard boxes.
Infusion solution 5%: vial 250 ml or 500 ml
Marketing Authorization Holder
Gematek, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: vial 250 ml or 500 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
250 ml – polyethylene vials (15) – cardboard boxes.
500 ml – polyethylene vials (10) – cardboard boxes.
Infusion solution 20%: vial 250 ml or 500 ml.
Marketing Authorization Holder
Gematek, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: vial 250 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
250 ml – polyethylene vials (15) – cardboard boxes.
500 ml – polyethylene vials (10) – cardboard boxes.
Solution for intravenous administration 400 mg/1 ml: 5 ml or 10 ml amp. 5 or 10 pcs.
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 400 mg/1 ml: 5 ml or 10 ml amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous administration transparent, colorless or slightly colored.
| 1 ml | |
| Dextrose monohydrate (calculated as dextrose) | 400 mg |
Excipients: sodium chloride – 0.26 mg, hydrochloric acid 0.1M solution – to pH 3.0-4.0, water for injections up to 1 ml.
5 ml – ampoules (5) – cardboard packs.
5 ml – ampoules (10) – cardboard packs.
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
Powder for oral solution, orange, strawberry or pineapple flavored 75 g: bottles or sachets
Marketing Authorization Holder
GTT, LLC (Russia)
Manufactured By
Pharmental Group, LLC (Russia)
Dosage Form
|
Glucose | Powder for oral solution, orange, strawberry or pineapple flavored 75 g: bottles or sachets |
Dosage Form, Packaging, and Composition
Powder for preparation of oral solution white or almost white with a faint characteristic odor or orange, or strawberry, or pineapple; formation of agglomerates/lumps is allowed, easily disintegrating upon pressure.
| 1 bottle/1 sachet | |
| Dextrose | 75 g* |
* 82.5 g dextrose monohydrate.
Excipients: citric acid, adipic acid, orange/strawberry/pineapple flavor.
84.4 g – bottles (1) – cardboard packs.
84.4 g – sachets made of combined material (1) – cardboard packs.
Solution for intravenous administration 250 mg/5 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 250 mg/5 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 50 mg | 250 mg |
5 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 500 mg/10 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 500 mg/10 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 50 mg | 500 mg |
10 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 500 mg/5 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 500 mg/5 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 100 mg | 500 mg |
5 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 1 g/10 ml: 10 pcs amp.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 1 g/10 ml: 10 pcs amp. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 100 mg | 1 g |
10 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 1.25 g/5 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 1.25 g/5 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 250 mg | 1.25 g |
5 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 2.5 g/10 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 2.5 g/10 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 250 mg | 2.5 g |
10 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 2 g/5 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 2 g/5 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 2 g |
5 ml – ampoules (10) – carton packs.
Solution for intravenous administration 4 g/10 ml: amp. 10 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 4 g/10 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (10) – carton packs.
Solution for infusion 5%: bottles 200 ml or 400 ml.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bottles 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
100 ml – bottles for blood and blood substitutes (1) – carton packs.
250 ml – bottles for blood and blood substitutes (1) – carton packs.
100 ml – bottles for blood and blood substitutes (35) – carton boxes.
200 ml – bottles for blood and blood substitutes (28) – carton boxes.
250 ml – bottles for blood and blood substitutes (28) – carton boxes.
400 ml – bottles for blood and blood substitutes (15) – carton boxes.
Solution for infusion 10%: bottles 100 ml, 200 ml, 300 ml or 400 ml
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: bottles 100 ml, 200 ml, 300 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
100 ml – bottles for blood and blood substitutes (1) – carton packs.
300 ml – bottles for blood and blood substitutes (1) – carton packs.
100 ml – bottles for blood and blood substitutes (35) – carton boxes.
200 ml – bottles for blood and blood substitutes (28) – carton boxes.
300 ml – bottles for blood and blood substitutes (15) – carton boxes.
400 ml – bottles for blood and blood substitutes (15) – carton boxes.
Infusion solution 20%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
200 ml – bottles for blood and blood substitutes (28) – carton boxes.
400 ml – bottles for blood and blood substitutes (15) – carton boxes.
Infusion solution 40%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Infusion solution 40%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 40% | 100 ml |
| Dextrose | 40 g |
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (15) – carton boxes.
200 ml – bottles for blood and blood substitutes (28) – carton boxes.
Infusion solution 10%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml from 6 to 96 pcs.
Marketing Authorization Holder
Medsintez Plant, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml from 6 to 96 pcs. |
Dosage Form, Packaging, and Composition
Solution for infusion as a colorless, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 100 g |
Excipients: 0.1M hydrochloric acid solution – to pH 3.0-4.5, water for injection – to 1 L.
Theoretical osmolarity 555 mOsmol/L.
50 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (50 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (96 pcs.) – carton boxes – for hospitals.
200 ml – containers with 2 ports (30 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (36 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (48 pcs.) – carton boxes – for hospitals.
400 ml – containers with 2 ports (15 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (18 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (6 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (9 pcs.) – carton boxes – for hospitals.
Infusion solution 5%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 1500 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, 4000 ml, 4500 ml, 5000 ml from 2 to 96 pcs.
Marketing Authorization Holder
Medsintez Plant, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 1500 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, 4000 ml, 4500 ml, 5000 ml from 2 to 96 pcs. |
Dosage Form, Packaging, and Composition
Solution for infusion as a colorless, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 50 g |
Excipients: sodium chloride – 0.26 g, 0.1 M hydrochloric acid solution – to pH 3.0-4.5, water for injection – to 1 L.
Theoretical osmolarity 277 mOsmol/L.
50 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (50 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (96 pcs.) – carton boxes – for hospitals.
200 ml – containers with 2 ports (30 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (36 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (48 pcs.) – carton boxes – for hospitals.
400 ml – containers with 2 ports (15 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (18 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (6 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (9 pcs.) – carton boxes – for hospitals.
1500 ml – containers with 2 ports (4 pcs.) – carton boxes – for hospitals.
2000 ml – containers with 2 ports (4 pcs.) – carton boxes – for hospitals.
2500 ml – containers with 2 ports (4 pcs.) – carton boxes – for hospitals.
3000 ml – containers with 2 ports (3 pcs.) – carton boxes – for hospitals.
3500 ml – containers with 2 ports (3 pcs.) – carton boxes – for hospitals.
4000 ml – containers with 2 ports (2 pcs.) – carton boxes – for hospitals.
4500 ml – containers with 2 ports (2 pcs.) – carton boxes – for hospitals.
5000 ml – containers with 2 ports (2 pcs.) – carton boxes – for hospitals.
Infusion solution 20%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml from 6 to 96 pcs.
Marketing Authorization Holder
Medsintez Plant, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: containers 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml from 6 to 96 pcs. |
Dosage Form, Packaging, and Composition
Solution for infusion as a slightly yellowish, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 200 g |
Excipients: 1M hydrochloric acid solution – to pH 3.0-4.5, water for injection – to 1 L.
Theoretical osmolarity 1110 mOsmol/L.
50 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (50 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (75 pcs.) – carton boxes – for hospitals.
100 ml – containers with 2 ports (96 pcs.) – carton boxes – for hospitals.
200 ml – containers with 2 ports (30 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (36 pcs.) – carton boxes – for hospitals.
250 ml – containers with 2 ports (48 pcs.) – carton boxes – for hospitals.
400 ml – containers with 2 ports (15 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (18 pcs.) – carton boxes – for hospitals.
500 ml – containers with 2 ports (24 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (12 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (6 pcs.) – carton boxes – for hospitals.
1000 ml – containers with 2 ports (9 pcs.) – carton boxes – for hospitals.
Infusion solution 5%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml
Marketing Authorization Holder
IST-Pharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml |
Dosage Form, Packaging, and Composition
Solution for infusion as a colorless, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 50 g |
Excipients: sodium chloride – 0.26 g, 0.1M hydrochloric acid solution – to pH 3.5-6.5, water for injection – to 1 L.
Theoretical osmolarity 286 mOsmol/L.
50 ml – polyethylene bottles (1) – carton packs.
100 ml – polyethylene bottles (1) – carton packs.
125 ml – polyethylene bottles (1) – carton packs.
200 ml – polyethylene bottles (1) – carton packs.
250 ml – polyethylene bottles (1) – carton packs.
400 ml – polyethylene bottles (1) – carton packs.
500 ml – polyethylene bottles (1) – carton packs.
Infusion solution 10%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml
Marketing Authorization Holder
IST-Pharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml |
Dosage Form, Packaging, and Composition
Solution for infusion as a colorless, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 100 g |
Excipients: sodium chloride – 0.26 g, 0.1M hydrochloric acid solution – to pH 3.5-6.5, water for injection – to 1 L.
Theoretical osmolarity 564 mOsmol/L.
50 ml – polyethylene bottles (1) – carton packs.
100 ml – polyethylene bottles (1) – carton packs.
125 ml – polyethylene bottles (1) – carton packs.
200 ml – polyethylene bottles (1) – carton packs.
250 ml – polyethylene bottles (1) – carton packs.
400 ml – polyethylene bottles (1) – carton packs.
500 ml – polyethylene bottles (1) – carton packs.
Infusion solution 20%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml
Marketing Authorization Holder
IST-Pharm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: bottle 50 ml, 100 ml, 125 ml, 200 ml, 250 ml, 400 ml or 500 ml |
Dosage Form, Packaging, and Composition
Solution for infusion as a slightly yellowish, transparent liquid.
| 1 L | |
| Dextrose monohydrate (calculated as dextrose) | 200 g |
Excipients: sodium chloride – 0.26 g, 0.1M hydrochloric acid solution – to pH 3.5-6.5, water for injection – to 1 L.
Theoretical osmolarity 1119 mOsmol/L.
50 ml – polyethylene bottles (1) – carton packs.
100 ml – polyethylene bottles (1) – carton packs.
125 ml – polyethylene bottles (1) – carton packs.
200 ml – polyethylene bottles (1) – carton packs.
250 ml – polyethylene bottles (1) – carton packs.
400 ml – polyethylene bottles (1) – carton packs.
500 ml – polyethylene bottles (1) – carton packs.
Solution for infusion 5%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs.
Marketing Authorization Holder
Kraspharma, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – glass bottles (1) – cardboard packs.
400 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (24) – cardboard boxes.
400 ml – glass bottles (12) – cardboard boxes.
Solution for infusion 10%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs.
Marketing Authorization Holder
Kraspharma, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – glass bottles (1) – cardboard packs.
400 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (24) – cardboard boxes.
400 ml – glass bottles (12) – cardboard boxes.
Solution for infusion 20%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs.
Marketing Authorization Holder
Kraspharma, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 20%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
200 ml – glass bottles (1) – cardboard packs.
400 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (24) – cardboard boxes.
400 ml – glass bottles (12) – cardboard boxes.
Solution for infusion 40%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs.
Marketing Authorization Holder
Kraspharma, PJSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 40%: 200 ml bottle 1 or 24 pcs., 400 ml bottle 1 or 12 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 40% | 100 ml |
| Dextrose | 40 g |
200 ml – glass bottles (1) – cardboard packs.
400 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (24) – cardboard boxes.
400 ml – glass bottles (12) – cardboard boxes.
Solution for infusion 5%: bottles 200 ml or 400 ml.
Marketing Authorization Holder
Kursk Biofactory – Firm “BIOK”, FSUE (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bottles 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Infusion solution 10%: bottle 200 ml or 400 ml.
Marketing Authorization Holder
Kursk Biofactory – Firm “BIOK”, FSUE (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: bottle 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Infusion solution 20%: bottle 200 ml or 400 ml.
Marketing Authorization Holder
Kursk Biofactory – Firm “BIOK”, FSUE (Russia)
Dosage Form
|
Glucose | Infusion solution 20%: bottle 200 ml or 400 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Powder for oral solution 75 g: 82.5 g jars
Marketing Authorization Holder
Lekar, LLC (Russia)
Dosage Form
|
Glucose | Powder for oral solution 75 g: 82.5 g jars |
Dosage Form, Packaging, and Composition
Powder for preparation of oral solution white or almost white, crystalline.
| 1 jar | |
| Dextrose monohydrate | 82.5 g, |
| Equivalent to dextrose content | 75 g |
82.5 g – jars – cardboard packs.
Solution for infusion 5%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Mosfarm LLC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs (28) – cardboard boxes.
200 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
200 ml – bottles for blood and blood substitutes (28) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs (15) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
Infusion solution 10%: bottle from 50 ml to 1000 ml or containers from 100 ml to 3000 ml
Marketing Authorization Holder
Mosfarm LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: bottle from 50 ml to 1000 ml or containers from 100 ml to 3000 ml |
Dosage Form, Packaging, and Composition
Solution for infusion as a clear, colorless liquid.
| 1 L | |
| Dextrose monohydrate, calculated as dextrose | 100 g |
Excipients : sodium chloride – 0.26 g, hydrochloric acid 0.1M – to pH 3.0-4.1, water for injections – to 1 L.
Theoretical osmolarity 555 mOsm/L.
100 ml, 200 ml or 400 ml – glass bottles (1) – cardboard packs.
50 ml, 75 ml, 100 ml, 150 ml, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml, 500 ml, 550 ml, 600 ml, 650 ml, 750 ml, 800 ml, 900 ml or 1000 ml – polymer bottles with self-destructing body (1) – cardboard packs.
100, 200, 250, 300, 400, 500, 600, 800, 1500, 2000 or 3000 ml – polymer containers (1) – polyethylene bags (1) – cardboard packs.
Solution for intravenous administration 40% (4 g/10 ml): amp. 10 pcs.
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 40% (4 g/10 ml): amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration 40% | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (10) – cardboard packs.
Infusion solution 5%: fl. 100 ml or 250 ml
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: fl. 100 ml or 250 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene bottles (1) – polyethylene bags.
250 ml – polyethylene bottles (1) – polyethylene bags.
Infusion solution 10%: fl. 100 ml or 250 ml
Marketing Authorization Holder
N.A. Semashko Moscow Chemical Pharmaceutical Preparations, JSC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: fl. 100 ml or 250 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene bottles (1) – polyethylene bags.
250 ml – polyethylene bottles (1) – polyethylene bags.
Solution for infusion 5%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Nesvizh Medical Products Plant OJSC (Republic Of Belarus)
Dosage Form
|
Glucose | Solution for infusion 5%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (40) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (24) – cardboard boxes.
Solution for infusion 10%: bottles 200 ml or 400 ml
Marketing Authorization Holder
Nesvizh Medical Products Plant OJSC (Republic Of Belarus)
Dosage Form
|
Glucose | Solution for infusion 10%: bottles 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (40) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (24) – cardboard boxes.
Solution for intravenous administration 2 g/5 ml: amp. 10 pcs.
Marketing Authorization Holder
Novosibkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 2 g/5 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 2 g |
5 ml – ampoules (10) – cardboard packs.
Solution for intravenous administration 4 g/10 ml: amp. 10 pcs.
Marketing Authorization Holder
Novosibkhimpharm, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 4 g/10 ml: amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (10) – cardboard packs.
Solution for infusion 5%: bottle 200 ml or 400 ml
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bottle 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (15) – cardboard boxes.
200 ml – bottles for blood and blood substitutes (28) – cardboard boxes.
Solution for intravenous administration 2 g/5 ml: amp. 5, 10, or 20 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 2 g/5 ml: amp. 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 2 g |
5 ml – ampoules (5) – cardboard packs.
5 ml – ampoules (10) – cardboard packs.
5 ml – ampoules (20) – cardboard packs.
Solution for intravenous administration 4 g/10 ml: amp. 5, 10, or 20 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 4 g/10 ml: amp. 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (5) – carton packs.
10 ml – ampoules (10) – carton packs.
10 ml – ampoules (20) – carton packs.
Solution for intravenous administration 8 g/20 ml: amp. 5, 10, or 20 pcs.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 8 g/20 ml: amp. 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 8 g |
20 ml – ampoules (5) – carton packs.
20 ml – ampoules (10) – carton packs.
20 ml – ampoules (20) – carton packs.
Solution for infusion 5%: bot. 100 ml, 200 or 400 ml
Marketing Authorization Holder
Promomed Rus LLC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: bot. 100 ml, 200 or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – bottles for blood and blood substitutes (1) – carton packs.
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
Solution for infusion 10%: bottle 100 ml, 200 or 400 ml
Marketing Authorization Holder
Promomed Rus LLC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: bottle 100 ml, 200 or 400 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
100 ml – bottles for blood and blood substitutes (1) – carton packs.
200 ml – bottles for blood and blood substitutes (1) – carton packs.
400 ml – bottles for blood and blood substitutes (1) – carton packs.
Infusion solution 5%: bottle 500 ml 1, 12 or 18 pcs.
Infusion solution 10%: bottle 500 ml 1, 12 or 18 pcs.
Marketing Authorization Holder
PFC Alium, LLC (Russia)
Dosage Forms
|
Glucose | Infusion solution 5%: bottle 500 ml 1, 12 or 18 pcs. |
| Infusion solution 10%: bottle 500 ml 1, 12 or 18 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Dextrose | 50 mg |
500 ml – bottles for blood and blood substitutes (1) – carton boxes.
500 ml – bottles for blood and blood substitutes (12) – carton boxes.
500 ml – bottles for blood and blood substitutes (18) – carton boxes.
| Solution for infusion | 1 ml |
| Dextrose | 100 mg |
500 ml – bottles for blood and blood substitutes (1) – carton packs.
500 ml – bottles for blood and blood substitutes (12) – carton boxes.
500 ml – bottles for blood and blood substitutes (18) – carton boxes.
Solution for infusion 5%: container 100 ml, 250 ml, 500 ml or 1000 ml.
Marketing Authorization Holder
Rester, CJS (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: container 100 ml, 250 ml, 500 ml or 1000 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polymer containers.
100 ml – polymer containers (70) – carton boxes.
250 ml – polymer containers (32) – carton boxes.
500 ml – polymer containers (20) – carton boxes.
1000 ml – polymer containers.
Solution for infusion 10%: container 250 ml or 500 ml.
Marketing Authorization Holder
Rester, CJS (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: container 250 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
250 ml – polymer containers (32) – carton boxes.
500 ml – polymer containers (20) – carton boxes.
Infusion solution 5%: bottle 400 ml 1 pc.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: bottle 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
Solution for infusion colorless, transparent.
| 1 L | |
| Dextrose monohydrate (calculated as anhydrous dextrose) | 50 g |
Excipients: sodium chloride – 0.26 g, hydrochloric acid solution 0.1M – to pH 3.0-4.1, water for injections – to 1 L.
400 ml – glass bottles for blood, transfusion and infusion preparations with a capacity of 450 ml (1) – carton packs.
Solution for infusion 10%: containers 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Sakhamedprom State Unitary Enterprise (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: containers 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polymer containers (80) – carton boxes.
200 ml – polymer containers (40) – carton boxes.
250 ml – polymer containers (40) – carton boxes.
400 ml – polymer containers (20) – carton boxes.
500 ml – polymer containers (14) – carton boxes.
Solution for infusion 5%: containers 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Sakhamedprom State Unitary Enterprise (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: containers 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polymer containers (80) – carton boxes.
200 ml – polymer containers (40) – carton boxes.
250 ml – polymer containers (40) – carton boxes.
400 ml – polymer containers (20) – carton boxes.
500 ml – polymer containers (14) – carton boxes.
Infusion solution 5%: containers 200 ml, 250 ml, 400 ml, 500 ml or 1 L
Marketing Authorization Holder
Sintez PJSC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: containers 200 ml, 250 ml, 400 ml, 500 ml or 1 L |
Dosage Form, Packaging, and Composition
Solution for infusion 5% transparent, colorless.
| 100 ml | |
| Dextrose | 5 g |
1 L – polymer containers (1) – polymer bags (1) – laminated aluminum foil bags.
1 L – polymer containers (5) – polymer bags (1) – laminated aluminum foil bags.
200 ml – polymer containers (1) – two-layer polypropylene bags.
200 ml – polymer containers (5) – polymer bags (1) – laminated aluminum foil bags.
250 ml – polymer containers (5) – polymer bags (1) – laminated aluminum foil bags.
400 ml – polymer containers (1) – polymer bags (1) – laminated aluminum foil bags.
400 ml – polymer containers (1) – polymer bags (3) – laminated aluminum foil bags.
400 ml – polymer containers (2) – polymer bags (1) – polyethylene bags.
400 ml – polymer containers (5) – polymer bags (1) – laminated aluminum foil bags.
500 ml – polymer containers (1) – polymer bags (3) – laminated aluminum foil bags.
500 ml – polymer containers (2) – polymer bags (1) – polyethylene bags.
500 ml – polymer containers (5) – polymer bags (1) – laminated aluminum foil bags.
Solution for intravenous administration 40%: 5 ml or 10 ml amp. 5 or 10 pcs.
Marketing Authorization Holder
Slavic Pharmacy, LLC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 40%: 5 ml or 10 ml amp. 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 100 ml |
| Dextrose | 40 g |
5 ml – polymer ampoules (5) – carton packs.
5 ml – polymer ampoules (10) – carton packs.
10 ml – polymer ampoules (5) – carton packs.
10 ml – polymer ampoules (10) – carton packs.
Infusion solution 5%: bag 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL
Marketing Authorization Holder
Statusfarm LLC (Russia)
Manufactured By
Pharmatek, CJSC (Armenia)
Dosage Form
|
Glucose | Infusion solution 5%: bag 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL |
Dosage Form, Packaging, and Composition
Solution for infusion transparent, colorless or slightly yellowish.
| 1000 ml | |
| Dextrose | 50 g |
Excipients: water for injections – to 1000 ml.
PH from 3.2 to 6.5.
Theoretical osmolarity – 278 mOsm/L.
100 ml – PVC bags (1) – carton packs.
200 ml – PVC bags (1) – carton packs.
250 ml – PVC bags (1) – carton packs.
400 ml – PVC bags (1) – carton packs.
500 ml – PVC bags (1) – carton packs.
Infusion solution 5%: container 100 ml, 250 ml, 500 ml or 1000 ml
Marketing Authorization Holder
Steritec Krasnodar Infusion Solutions Plant LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: container 100 ml, 250 ml, 500 ml or 1000 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polymer containers (32) – carton boxes.
250 ml – polymer containers (32) – carton boxes.
500 ml – polymer containers (20) – carton boxes.
1000 ml – polymer containers (10) – carton boxes.
Infusion solution 10%: container 100 ml, 250 ml, 500 ml or 1000 ml
Marketing Authorization Holder
Steritec Krasnodar Infusion Solutions Plant LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: container 100 ml, 250 ml, 500 ml or 1000 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion | 100 ml |
| Dextrose | 10 g |
100 ml – polymer containers (32) – carton boxes.
250 ml – polymer containers (32) – carton boxes.
500 ml – polymer containers (20) – carton boxes.
1000 ml – polymer containers (10) – carton boxes.
Infusion solution 5%: bottle 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pharma International Company Russia-CIS, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: bottle 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
200 ml – polyethylene bottles (1) – carton packs.
250 ml – polyethylene bottles (1) – carton packs.
400 ml – polyethylene bottles (1) – carton packs.
500 ml – polyethylene bottles (1) – carton packs.
Infusion solution 10%: bottle 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pharma International Company Russia-CIS, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: bottle 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
200 ml – polyethylene bottles (1) – carton packs.
250 ml – polyethylene bottles (1) – carton packs.
400 ml – polyethylene bottles (1) – carton packs.
500 ml – polyethylene bottles (1) – carton packs.
Solution for intravenous administration 400 mg/1 ml: 5 ml or 10 ml amp. 10 pcs.
Marketing Authorization Holder
Pharmasintez, JSC (Russia)
Dosage Form
|
Glucose | Solution for intravenous administration 400 mg/1 ml: 5 ml or 10 ml amp. 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous administration in the form of a slightly yellowish, transparent liquid.
| 1 ml | |
| Dextrose monohydrate (calculated as dextrose) | 400 mg |
Excipients: sodium chloride – 0.26 mg, hydrochloric acid solution 0.1 M – to pH 3.0-4.1, water for injections – to 1 ml.
5 ml – polyethylene ampoules (10), connected in cassettes – cardboard packs.
10 ml – polyethylene ampoules (10), connected in cassettes – cardboard packs.
Infusion solution 10%: containers 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pharmasintez-Tyumen, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 10%: containers 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
250 ml – polyethylene bottles (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
500 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Infusion solution 5%: containers 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pharmasintez-Tyumen, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: containers 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
250 ml – polyethylene bottles (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
500 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Infusion solution 5%: bottle 50 mL, 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL
Infusion solution 10%: bottle 50 mL, 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL
Marketing Authorization Holder
Pharmasintez-Tyumen, LLC (Russia)
Dosage Forms
|
Glucose | Infusion solution 5%: bottle 50 mL, 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL |
| Infusion solution 10%: bottle 50 mL, 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL |
Dosage Form, Packaging, and Composition
Infusion solution in the form of a transparent, colorless liquid.
| 1 L | |
| Dextrose (in the form of monohydrate) | 50 g |
Excipients: sodium chloride – 0.26 g, hydrochloric acid solution 1M – to pH 3.2-6.5, water for injections – to 1 L.
Theoretical osmolarity – 286 mOsm/L.
50 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
100 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
200 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
250 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
400 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
500 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
Infusion solution in the form of a transparent, colorless liquid.
| 1 L | |
| Dextrose (in the form of monohydrate) | 100 g |
Excipients: sodium chloride – 0.26 g, hydrochloric acid solution 1M – to pH 3.2-6.5, water for injections – to 1 L.
Theoretical osmolarity – 564 mOsm/L.
50 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
100 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
200 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
250 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
400 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
500 ml – low-density polyethylene bottles (1) – polymer film bags/without bag – cardboard packs.
Infusion solution 5%: containers 100 ml, 250 ml, 500 ml or 1000 ml 1 pc.
Marketing Authorization Holder
Pharmland SP, LLC (Republic of Belarus)
Dosage Form
|
Glucose | Infusion solution 5%: containers 100 ml, 250 ml, 500 ml or 1000 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
250 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
Infusion solution 10%: containers 250 ml or 500 ml 1 pc.
Marketing Authorization Holder
Pharmland SP, LLC (Republic of Belarus)
Dosage Form
|
Glucose | Infusion solution 10%: containers 250 ml or 500 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
250 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
Tablets 500 mg: 10, 20, 50, or 100 pcs.
Marketing Authorization Holder
Pharmstandard-Tomskkhimpharm OJSC (Russia)
Manufactured By
Pharmstandard-Lexredstva OJSC (Russia)
Dosage Form
 |
Glucose | Tablets 500 mg: 10, 20, 50, or 100 pcs. |
Dosage Form, Packaging, and Composition
Tablets white, round, flat-cylindrical, with a bevel and a score.
| 1 tab. | |
| Dextrose monohydrate | 500 mg |
Excipients: talc – 6 mg, stearic acid – 4 mg.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
Powder for oral solution 75 g: sachets
Marketing Authorization Holder
Pharmkhimkomplekt NPC, LLC (Russia)
Manufactured By
Technopark-Center LLC (Russia)
Dosage Form
|
Glucose | Powder for oral solution 75 g: sachets |
Dosage Form, Packaging, and Composition
Powder for preparation of oral solution white, crystalline.
| 1 sachet | |
| Dextrose monohydrate | 82.5 g, |
| Which corresponds to dextrose content | 75 g |
82.5 g – sachets.
82.5 g – sachets (50) – cardboard boxes (for hospitals).
82.5 g – sachets (100) – cardboard boxes (for hospitals).
82.5 g – sachets (200) – cardboard boxes (for hospitals).
Solution for infusion 5%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers
Marketing Authorization Holder
Medpolymer Firm, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 5%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 100 ml |
| Dextrose | 5 g |
50 ml – polymer containers (1) – polyethylene bags.
100 ml – polymer containers (1) – polyethylene bags.
250 ml – polymer containers (1) – polyethylene bags.
200 ml – polymer containers (1) – polyethylene bags.
400 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
1 L – polymer containers (1) – polyethylene bags.
Solution for infusion 10%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers
Marketing Authorization Holder
Medpolymer Firm, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 10%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 100 ml |
| Dextrose | 10 g |
50 ml – polymer containers (1) – polyethylene bags.
100 ml – polymer containers (1) – polyethylene bags.
250 ml – polymer containers (1) – polyethylene bags.
200 ml – polymer containers (1) – polyethylene bags.
400 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
1 L – polymer containers (1) – polyethylene bags.
Solution for infusion 20%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers
Marketing Authorization Holder
Medpolymer Firm, JSC (Russia)
Dosage Form
|
Glucose | Solution for infusion 20%: 50 ml, 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, or 1000 ml containers |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 100 ml |
| Dextrose | 20 g |
50 ml – polymer containers (1) – polyethylene bags.
100 ml – polymer containers (1) – polyethylene bags.
250 ml – polymer containers (1) – polyethylene bags.
200 ml – polymer containers (1) – polyethylene bags.
400 ml – polymer containers (1) – polyethylene bags.
500 ml – polymer containers (1) – polyethylene bags.
1 L – polymer containers (1) – polyethylene bags.
Infusion solution 5%: 200 ml bottle 1 or 28 pcs., 400 ml bottle 1 or 15 pcs.
Marketing Authorization Holder
Advanced Perm, LLC (Russia)
Dosage Form
|
Glucose | Infusion solution 5%: 200 ml bottle 1 or 28 pcs., 400 ml bottle 1 or 15 pcs. |
Dosage Form, Packaging, and Composition
Infusion solution transparent, colorless.
| 100 ml | |
| Dextrose monohydrate | 5 g |
Excipients: sodium chloride – 26 mg, hydrochloric acid solution 0.1 M – to pH 3.0-4.5, water for injections – to 100 ml.
Theoretical osmolarity: 286 mOsm/L.
200 ml – glass bottles (1) – cardboard packs.
400 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (28) – cardboard boxes (for hospitals).
400 ml – glass bottles (15) – cardboard boxes (for hospitals).
Infusion solution 5%: bottle 100 mL, 250 mL, 500 mL, or 1 L
Marketing Authorization Holder
B.Braun Melsungen AG (Germany)
Dosage Form
|
Glucose Braun | Infusion solution 5%: bottle 100 mL, 250 mL, 500 mL, or 1 L |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene bottles (20) – cardboard boxes.
250 ml – polyethylene bottles (10) – cardboard boxes.
500 ml – polyethylene bottles (10) – cardboard boxes.
1 L – polyethylene bottles (10) – cardboard boxes.
Infusion solution 10%: bottle 500 mL or 1 L
Marketing Authorization Holder
B.Braun Melsungen AG (Germany)
Dosage Form
|
Glucose Braun | Infusion solution 10%: bottle 500 mL or 1 L |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
500 ml – polyethylene bottles (10) – cardboard boxes.
1 L – polyethylene bottles (10) – cardboard boxes.
Solution for intravenous administration 400 mg/1 mL: amp. 5 mL or 10 mL 10 or 100 pcs.
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
Dosage Form
|
Glucose Bufus® | Solution for intravenous administration 400 mg/1 mL: amp. 5 mL or 10 mL 10 or 100 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous administration in the form of a transparent, colorless or with a slight brownish-yellowish tint liquid.
| 1 ml | |
| Dextrose monohydrate (calculated as dry substance dextrose) | 400 mg |
Excipients: sodium chloride – 0.26 mg, hydrochloric acid solution 0.1M – to pH 3.0-4.0, water for injections – to 1 ml.
5 ml – ampoules (10) – cardboard packs.
5 ml – ampoules (100) – cardboard packs.
5 ml – ampoules (100) – cardboard boxes.
10 ml – ampoules (10) – cardboard packs.
10 ml – ampoules (100) – cardboard packs.
10 ml – ampoules (100) – cardboard boxes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Altai Krai Blood Transfusion Station SMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Altai Krai Blood Transfusion Station SMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Altai Krai Blood Transfusion Station SMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Armavirproduct, OJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Armavirproduct, OJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Armavirproduct, OJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Armavirproduct, OJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biy Blood Transfusion Station MMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Biy Blood Transfusion Station MMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biy Blood Transfusion Station MMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biy Blood Transfusion Station MMU (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Vostok JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Vostok JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Vostok JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Vostok JSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Lekko, CJS (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Lekko, CJS (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Lekko, CJS (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Lekko, CJS (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Panda CJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Panda CJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Panda CJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Panda CJSC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pokrovsky Plant of Biopreparations, FSUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Pokrovsky Plant of Biopreparations, FSUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pokrovsky Plant of Biopreparations, FSUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Pokrovsky Plant of Biopreparations, FSUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk City Blood Transfusion Station MUP (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Rubtsovsk City Blood Transfusion Station MUP (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk City Blood Transfusion Station MUP (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk City Blood Transfusion Station MUP (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Samson-Med LLC (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk Blood Transfusion Station SUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 10%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 100 ml |
| Dextrose | 10 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml.
Marketing Authorization Holder
Rubtsovsk Blood Transfusion Station SUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 20%: bottle 100 ml, 200 ml, 250 ml, 400 ml, or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 100 ml |
| Dextrose | 20 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk Blood Transfusion Station SUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 40%: bot. 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 40% | 100 ml |
| Dextrose | 40 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml.
Marketing Authorization Holder
Rubtsovsk Blood Transfusion Station SUE (Russia)
Dosage Form
|
Glucose solution for infusions | Infusion solution 5%: bottle 100 ml, 200 ml, 250 ml, 400 ml or 500 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 100 ml |
| Dextrose | 5 g |
100 ml – polyethylene containers.
200 ml – bottles for blood and blood substitutes.
250 ml – polyethylene containers.
400 ml – bottles for blood and blood substitutes.
500 ml – bottles for blood and blood substitutes.
Infusion solution 5%: bottle 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL
Infusion solution 10%: bottle 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL
Marketing Authorization Holder
Mir Chemical and Pharmaceutical Concern, LLC (Russia)
Manufactured By
NPC Eskom, PJSC (Russia)
Dosage Forms
|
Glucose-E | Infusion solution 5%: bottle 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL |
| Infusion solution 10%: bottle 100 mL, 200 mL, 250 mL, 400 mL, or 500 mL |
Dosage Form, Packaging, and Composition
Infusion solution as a transparent, colorless liquid.
| 1 L | |
| Dextrose (as monohydrate) | 50 g |
Excipients: sodium chloride – 0.26 g, 0.1M hydrochloric acid solution – to pH 3-4.1 (or to pH 3-6), water for injections – to 1 L.
100 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
200 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
400 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
500 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
100 ml – polymer bottles (1) – cardboard packs.
200 ml – polymer bottles (1) – cardboard packs.
250 ml – polymer bottles (1) – cardboard packs.
400 ml – polymer bottles (1) – cardboard packs.
500 ml – polymer bottles (1) – cardboard packs.
Infusion solution as a transparent, colorless liquid.
| 1 L | |
| Dextrose (as monohydrate) | 100 g |
Excipients: sodium chloride – 0.26 g, 0.1M hydrochloric acid solution – to pH 3-4.1 (or to pH 3-6), water for injections – to 1 L.
100 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
200 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
400 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
500 ml – glass bottles for blood, transfusion and infusion preparations (1) – cardboard packs.
100 ml – polymer bottles (1) – cardboard packs.
200 ml – polymer bottles (1) – cardboard packs.
250 ml – polymer bottles (1) – cardboard packs.
400 ml – polymer bottles (1) – cardboard packs.
500 ml – polymer bottles (1) – cardboard packs.
Solution for intravenous administration 4 g/10 ml: amp. 5, 10, or 20 pcs.
Marketing Authorization Holder
Mir Chemical and Pharmaceutical Concern, LLC (Russia)
Dosage Form
|
Glucose-Eskom | Solution for intravenous administration 4 g/10 ml: amp. 5, 10, or 20 pcs. |
Dosage Form, Packaging, and Composition
| Solution for intravenous administration | 1 ml | 1 amp. |
| Dextrose | 400 mg | 4 g |
10 ml – ampoules (10) – plastic contour packs (1) – cardboard packs.
10 ml – ampoules (10) – plastic contour packs (2) – cardboard packs.
10 ml – ampoules (5) – plastic contour packs (1) – cardboard packs.
10 ml – ampoules (5) – plastic contour packs (2) – cardboard packs.
Infusion solution 5%: 100 mL, 200 mL, 250 mL, 400 mL, 500 mL, or 1000 mL vial
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
|
Glucose-SOLOpharm | Infusion solution 5%: 100 mL, 200 mL, 250 mL, 400 mL, 500 mL, or 1000 mL vial |
Dosage Form, Packaging, and Composition
Infusion solution transparent, colorless.
| 1 L | |
| Dextrose monohydrate | 50 g |
Excipients: sodium chloride 0.26 g, water for injections to 1 L.
Theoretical osmolarity 286 mOsm/L.
100 ml – polypropylene vials (1) – cardboard packs.
200 ml – polypropylene vials (1) – cardboard packs.
250 ml – polypropylene vials (1) – cardboard packs.
400 ml – polypropylene vials (1) – cardboard packs.
500 ml – polypropylene vials (1) – cardboard packs.
1000 ml – polypropylene vials (1) – cardboard packs.
100 ml – polypropylene vials (30) – cardboard boxes (for hospitals).
200 ml – polypropylene vials (20) – cardboard boxes (for hospitals).
250 ml – polypropylene vials (20) – cardboard boxes (for hospitals).
400 ml – polypropylene vials (20) – cardboard boxes (for hospitals).
500 ml – polypropylene vials (20) – cardboard boxes (for hospitals).
1000 ml – polypropylene vials (10) – cardboard boxes (for hospitals).
Infusion solution 10%: 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml bottle.
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
|
Glucose-SOLOpharm | Infusion solution 10%: 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml bottle. |
Dosage Form, Packaging, and Composition
Infusion solution transparent, colorless.
| 1 L | |
| Dextrose monohydrate | 100 g |
Excipients: sodium chloride 0.26 g, water for injections to 1 L.
Theoretical osmolarity 564 mOsm/L.
100 ml – polypropylene bottles (1) – cardboard packs.
200 ml – polypropylene bottles (1) – cardboard packs.
250 ml – polypropylene bottles (1) – cardboard packs.
400 ml – polypropylene bottles (1) – cardboard packs.
500 ml – polypropylene bottles (1) – cardboard packs.
1000 ml – polypropylene bottles (1) – cardboard packs.
100 ml – polypropylene bottles (30) – cardboard boxes (for hospitals).
200 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
250 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
400 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
500 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
1000 ml – polypropylene bottles (10) – cardboard boxes (for hospitals).
Infusion solution 20%: 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml bottle.
Marketing Authorization Holder
Grotex, LLC (Russia)
Dosage Form
|
Glucose-SOLOpharm | Infusion solution 20%: 100 ml, 200 ml, 250 ml, 400 ml, 500 ml or 1000 ml bottle. |
Dosage Form, Packaging, and Composition
Infusion solution transparent, colorless or slightly yellowish.
| 1 L | |
| Dextrose monohydrate | 200 g |
Excipients: sodium chloride 0.26 g, water for injections to 1 L.
Theoretical osmolarity 1120 mOsm/L.
100 ml – polypropylene bottles (1) – cardboard packs.
200 ml – polypropylene bottles (1) – cardboard packs.
250 ml – polypropylene bottles (1) – cardboard packs.
400 ml – polypropylene bottles (1) – cardboard packs.
500 ml – polypropylene bottles (1) – cardboard packs.
1000 ml – polypropylene bottles (1) – cardboard packs.
100 ml – polypropylene bottles (30) – cardboard boxes (for hospitals).
200 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
250 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
400 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
500 ml – polypropylene bottles (20) – cardboard boxes (for hospitals).
1000 ml – polypropylene bottles (10) – cardboard boxes (for hospitals).
Infusion solution 10%: bot. 200 ml 1 or 40 pcs., bot. 400 ml 1 or 30 pcs.
Marketing Authorization Holder
Vial, LLC (Russia)
Manufactured By
Hebei Tiancheng Pharmaceutical Co., Ltd (China)
Dosage Form
|
Glucose-Vial | Infusion solution 10%: bot. 200 ml 1 or 40 pcs., bot. 400 ml 1 or 30 pcs. |
Dosage Form, Packaging, and Composition
| Infusion solution | 100 ml |
| Dextrose | 10 g |
200 ml – polypropylene bottles (1) – cardboard packs.
400 ml – polypropylene bottles (1) – cardboard packs.
200 ml – polypropylene bottles (40) – cardboard boxes (for hospitals).
400 ml – polypropylene bottles (30) – cardboard boxes (for hospitals).
Infusion solution 5%: bottle 200 ml 1 or 40 pcs., bottle 400 ml 1 or 30 pcs.
Marketing Authorization Holder
Vial, LLC (Russia)
Manufactured By
Hebei Tiancheng Pharmaceutical Co., Ltd (China)
Dosage Form
|
Glucose-Vial | Infusion solution 5%: bottle 200 ml 1 or 40 pcs., bottle 400 ml 1 or 30 pcs. |
Dosage Form, Packaging, and Composition
| Infusion solution | 100 ml |
| Dextrose | 5 g |
200 ml – polypropylene bottles (1) – cardboard packs.
400 ml – polypropylene bottles (1) – cardboard packs.
200 ml – polypropylene bottles (40) – cardboard boxes (for hospitals).
400 ml – polypropylene bottles (30) – cardboard boxes (for hospitals).
![Glucose [Tablets, Solution, Powder] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Glucose [Tablets, Solution, Powder] 2")